According to a report from Reuters, Philip Morris International (PMI) is planning to build a new factory in the Lviv region of western Ukraine that will cost $30 million and be operational in the first quarter of 2024. Maksym Barabash, CEO of PMI Ukraine, stated in a release that the company is committed to investing in Ukraine's future and that the new factory will be a significant development in advancing this goal.
This investment reflects our commitment as a long-term economic partner in Ukraine. We are not waiting for the end of the war, we are investing now.
PMI has announced that the factory will create 250 job opportunities. Due to the impact of the Russia-Ukraine conflict, Ukraine urgently needs foreign capital to rebuild and improve its economy. In 2022, Ukraine's GDP fell by 29.2%, the largest decline since the country gained independence. However, Ukrainian officials and analysts predict that the economy will grow this year as businesses adapt to the new wartime situation.
Since 1994, PMI has invested over $700 million in Ukraine.
Reference:
Philip Morris, the tobacco giant, is set to open a new production facility in western Ukraine worth $30 million.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
